Literature DB >> 31770631

Emergence of Haitian variant genotype and altered drug susceptibility in Vibrio cholerae O1 El Tor-associated cholera outbreaks in Solapur, India.

Pramod Kumar1, Priti Yadav2, Kishor V Ingole3, Rishi K Jaiswal2, Nasira S Khalid3, Durgesh G Deshmukh4, Ajay K Goel5, Pramod K Yadava6.   

Abstract

It is evident from previous cholera epidemics/outbreaks in India, Africa and America that isolates of the seventh pandemic Vibrio cholerae El Tor (7PET) with Haitian cholera toxin (HCT) genotype were associated with increased mortality. The present study highlights the emergence of 7PET-HCT isolates causing two cholera outbreaks in Walsang and Wagdari (Solapur, India) in 2016. Molecular analyses revealed that 7PET strains from earlier outbreaks (2010 and 2012) were progenitors of the current 7PET-HCT isolates. Isolates from the 2016 outbreaks carried qnrVC and floR genes and showed reduced susceptibility to tetracycline, ciprofloxacin and azithromycin, drugs recommended by the World Health Organization (WHO) for the treatment of cholera. Remarkably, protein profiling and mass spectrometry revealed disappearance of the outer membrane protein U (OmpU) porin in 7PET-HCT isolates from the second outbreak in 2016. Downregulation of ompU gene expression was also confirmed at the transcriptional level. Strains with downregulated OmpU showed reduced minimum inhibitory concentrations (MICs) for polymyxin B, which is a pore-forming antimicrobial agent. A multipronged approach is of utmost importance to prevent further spread of circulating 7PET-HCT strains. There is a pressing need for the formulation and implementation of international policies to closely monitor the effective use of antibiotics in order to prevent the further rise and spread of antimicrobial resistance.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Cholera; Haitian cholera toxin; OmpU; qnrVC

Mesh:

Substances:

Year:  2019        PMID: 31770631     DOI: 10.1016/j.ijantimicag.2019.11.010

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  1 in total

1.  A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model.

Authors:  Rahsan Erdem; Gwen Ambler; Mohamed Al-Ibrahim; Katarzyna Fraczek; Steven D Dong; Christopher Gast; Laina D Mercer; Michael Raine; Sharon M Tennant; Wilbur H Chen; Eugenio L de Hostos; Robert K M Choy
Journal:  PLoS Negl Trop Dis       Date:  2021-11-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.